XENOCOR in the News:

FDA
Xenocor Announces FDA Clearance of Saberscope®, the First Single-Use 5mm Articulating Laparoscope for Enhanced Surgical VisualizationPress Release

Xenocor Announces FDA Clearance of Saberscope®, the First Single-Use 5mm Articulating Laparoscope for Enhanced Surgical Visualization

March 17, 2026
Xenocor Awarded U.S. Patent for Breakthrough in Medical Borescope Technology
Xenocor Awarded U.S. Patent for Breakthrough in Medical Borescope TechnologyPress Release

Xenocor Awarded U.S. Patent for Breakthrough in Medical Borescope Technology

October 7, 2025
Future of Laparoscopic Visualization
Xenocor Completes Oversubscribed $10 million Series A to Lead the Future of Laparoscopic VisualizationPress Release

Xenocor Completes Oversubscribed $10 million Series A to Lead the Future of Laparoscopic Visualization

April 24, 2023
saberscope-xenocor
USPTO Grants Xenocor Fourth US Patent, Achieving Increased Protection for their Novel Saberscope SystemPress Release

USPTO Grants Xenocor Fourth US Patent, Achieving Increased Protection for their Novel Saberscope System

August 29, 2022
Mark Foster
Xenocor Expands Board of Directors to Accelerate Innovation & LaunchPress Release

Xenocor Expands Board of Directors to Accelerate Innovation & Launch

September 22, 2021
Trudell Medical
Trudell Medical Group Makes a Strategic Investment in Xenocor, Developer of the XenoscopePress Release

Trudell Medical Group Makes a Strategic Investment in Xenocor, Developer of the Xenoscope

June 22, 2021